[1]
|
Matijašić, M., Meštrović, T., Čipčić Paljetak, H.C., et al. (2020) Gut Microbiota beyond Bacteria—Mycobiome, Virome, Archaeome, and Eukaryotic Parasites in IBD. International Journal of Molecular Sciences, 21, Article No. 2668.
https://doi.org/10.3390/ijms21082668
|
[2]
|
Jayasudha, R., Das, T., Kalyana, C.S., et al. (2020) Gut Mycobiomes Are Altered in People with Type 2 Diabetes Mellitus and Diabetic Retinopathy. PLOS ONE, 15, e243077. https://doi.org/10.1371/journal.pone.0243077
|
[3]
|
Mazloom, K., Siddiqi, I. and Covasa, M. (2019) Probiotics: How Effective Are They in the Fight against Obesity? Nutrients, 11, Article No. 258. https://doi.org/10.3390/nu11020258
|
[4]
|
Wang, C., Li, Q. and Ren, J. (2019) Microbiota-Immune Interaction in the Pathogenesis of Gut-Derived Infection. Frontiers in Immunology, 10, Article 1873. https://doi.org/10.3389/fimmu.2019.01873
|
[5]
|
Williams, R., Karuranga, S., Malanda, B., et al. (2020) Global and Regional Estimates and Projections of Diabetes-Related Health Expenditure: Results from the International Diabetes Fed-eration Diabetes Atlas, 9th Edition. Diabetes Research and Clinical Practice, 162, Article ID: 108072. https://doi.org/10.1016/j.diabres.2020.108072
|
[6]
|
Silveira Rossi, J.L., Barbalho, S.M., de Araujo, R.R., et al. (2022) Metabolic Syndrome and Cardiovascular Diseases: Going beyond Traditional Risk Factors. Diabetes/Metabolism Research and Reviews, 38, e3502.
https://doi.org/10.1002/dmrr.3502
|
[7]
|
Iatcu, C.O., Steen, A. and Covasa, M. (2021) Gut Microbiota and Compli-cations of Type-2 Diabetes. Nutrients, 14, Article No. 166. https://doi.org/10.3390/nu14010166
|
[8]
|
Lee, C.B., Chae, S.U., Jo, S.J., Jerng, U.M. and Bae, S.K. (2021) The Relationship between the Gut Microbiome and Metformin as a Key for Treating Type 2 Diabetes Mellitus. International Journal of Molecular Sciences, 22, Article No. 3566. https://doi.org/10.3390/ijms22073566
|
[9]
|
Chen, W., Zhang, M., Guo, Y, et al. (2021) The Profile and Function of Gut Microbiota in Diabetic Nephropathy. Diabetes, Metabolic Syndrome and Obesity, 14, 4283-4296. https://doi.org/10.2147/DMSO.S320169
|
[10]
|
Tian, R., Liu, H., Feng, S., et al. (2021) Gut Microbiota Dysbiosis in Stable Coronary Artery Disease Combined with Type 2 Diabetes Mellitus Influences Cardiovascular Prognosis. Nutrition, Metabolism and Cardiovascular Diseases, 31, 1454-1466. https://doi.org/10.1016/j.numecd.2021.01.007
|
[11]
|
Zhu, Q., Gao, R., Zhang, Y., et al. (2018) Dysbiosis Signatures of Gut Microbiota in Coronary Artery Disease. Physiological Genomics, 50, 893-903. https://doi.org/10.1152/physiolgenomics.00070.2018
|
[12]
|
Rodríguez-Morató, J. and Mat-than, N.R. (2020) Nutrition and Gastrointestinal Microbiota, Microbial-Derived Secondary Bile Acids, and Cardiovascu-lar Disease. Current Atherosclerosis Reports, 22, Article No. 47.
https://doi.org/10.1007/s11883-020-00863-7
|
[13]
|
Kim, S.M. and Song, I.H. (2020) The Clinical Impact of Gut Microbiota in Chronic Kidney Disease. Korean Journal of Internal Medicine, 35, 1305-1316. https://doi.org/10.3904/kjim.2020.411
|
[14]
|
Rukavina Mikusic, N.L., Kouyoumdzian, N.M. and Choi, M.R. (2020) Gut Microbiota and Chronic Kidney Disease: Evidences and Mechanisms That Mediate a New Communication in the Gastrointestinal-Renal Axis. Pflügers Archiv, 472, 303-320. https://doi.org/10.1007/s00424-020-02352-x
|
[15]
|
Meijers, B., Evenepoel, P. and Anders, H.-J. (2019) Intestinal Microbiome and Fitness in Kidney Disease. Nature Reviews Nephrology, 15, 531-545. https://doi.org/10.1038/s41581-019-0172-1
|
[16]
|
Chung, S.Y., Barnes, J.L. and Astroth, K.S. (2019) Gastrointesti-nal Microbiota in Patients with Chronic Kidney Disease: A Systematic Review. Advances in Nutrition, 10, 888-901. https://doi.org/10.1093/advances/nmz028
|
[17]
|
Rodrigues, F.G., Ormanji, M.S., Heilberg, I.P., et al. (2021) Inter-play between Gut Microbiota, Bone Health and Vascular Calcification in Chronic Kidney Disease. European Journal of Clinical Investigation, 51, e13588.
https://doi.org/10.1111/eci.13588
|
[18]
|
Wei, H., Wang, L., An, Z., et al. (2021) QiDiTangShen Granules Modulated the Gut Microbiome Composition and Improved Bile Acid Proles in a Mouse Model of Diabetic Nephropathy. Biomedi-cine & Pharmacotherapy, 133, Article ID: 111061. https://doi.org/10.1016/j.biopha.2020.111061
|
[19]
|
McFarlane, C., Krishnasamy, R., Stanton, T., et al. (2021) Synbiotics Easing Renal Failure by Improving Gut Microbiology II (SYNERGY II): A Feasibility Randomized Controlled Trial. Nutrients, 13, Article No. 4481.
https://doi.org/10.3390/nu13124481
|
[20]
|
Zhou, H., Peng, C., Huang, D.-S., et al. (2020) microRNA Expression Profiling Based on Microarray Approach in Human Diabetic Retinopathy: A Systematic Review and Meta-Analysis. DNA and Cell Biology, 39, 441-450.
https://doi.org/10.1089/dna.2019.4942
|
[21]
|
Cecilia, O.-M., Jose, A.-C., Jose, N.-P., et al. (2019) Oxidative Stress as the Main Target in Diabetic Retinopathy Pathophysiology. Journal of Diabetes Research, 2019, Article ID: 8562408. https://doi.org/10.1155/2019/8562408
|
[22]
|
Ozkan, J., Willcox, M., Wemheuer, B., et al. (2019) Biogeography of the Human Ocular Microbiota. The Ocular Surface, 17, 111-118. https://doi.org/10.1016/j.jtos.2018.11.005
|
[23]
|
Das, T., Jayasudha, R., Chakravarthy, S., et al. (2021) Alterations in the Gut Bacterial Microbiome in People with Type 2 Diabetes Mellitus and Diabetic Retinopathy. Scientific Reports, 11, Article No. 2738.
https://doi.org/10.1038/s41598-021-82538-0
|
[24]
|
Verma, A., Xu, K., Du, T., et al. (2019) Expression of Human ACE2 in Lactobacillus and Beneficial Effects in Diabetic Retinopathy in Mice. Molecular Therapy—Methods & Clinical Development, 14, 161-170.
https://doi.org/10.1016/j.omtm.2019.06.007
|
[25]
|
Lin, K., Fan, K., Mu, S. and Wang, S. (2022) Change in Cepha-locaudal Tumor Cavity Diameter after Transsphenoidal Surgery Is A Predictor of Diabetes Insipidus in Pituitary Adeno-ma. European Journal of Medical Research, 27, Article No. 72. https://doi.org/10.1186/s40001-022-00700-4
|
[26]
|
Garg, A., Chilakamarri, P. and Koo, B.B. (2021) Diagnostic and Treatment Considerations in Restless Legs Syndrome Complicated by Diabetic Neuropathy. Current Diabetes Reports, 21, Article No. 66.
https://doi.org/10.1007/s11892-021-01431-2
|
[27]
|
Paul, S., Ali, A. and Katare, R. (2020) Molecular Complexities Underlying the Vascular Complications of Diabetes Mellitus—A Comprehensive Review. Journal of Diabetes and Its Complications, 34, Article ID: 107613.
https://doi.org/10.1016/j.jdiacomp.2020.107613
|
[28]
|
Preguica, I., Alves, A., Nunes, S., et al. (2021) Diet-Induced Rodent Models of Diabetic Peripheral Neuropathy, Retinopathy and Nephropathy. Nutrients, 12, Article No. 250. https://doi.org/10.3390/nu12010250
|
[29]
|
Hicks, C.W. and Selvin, E. (2019) Epidemiology of Peripheral Neuropa-thy and Lower Extremity Disease in Diabetes. Current Diabetes Reports, 19, Article No. 86. https://doi.org/10.1007/s11892-019-1212-8
|
[30]
|
Pathak, R., Sachan, N. and Chandra, P. (2022) Mechanistic Ap-proach towards Diabetic Neuropathy Screening Techniques and Future Challenges: A Review. Biomedicine & Pharma-cotherapy, 150, Article ID: 113025.
https://doi.org/10.1016/j.biopha.2022.113025
|
[31]
|
Rolim, L.C., da Silva, E.M., Flumignan, R.L., Abreu, M.M. and Dib, S.A. (2019) Acetyl-L-Carnitine for the Treatment of Diabetic Peripheral Neuropathy. Cochrane Database of Sys-tematic Reviews, 6, Article No. D11265.
https://doi.org/10.1002/14651858.CD011265.pub2
|
[32]
|
Wang, Y., Ye, X., Ding, D. and Lu, Y. (2020) Character-istics of the Intestinal Flora in Patients with Peripheral Neuropathy Associated with Type 2 Diabetes. Journal of Interna-tional Medical Research, 48.
https://doi.org/10.1177/0300060520936806
|
[33]
|
Zaharuddin, L., Mokhtar, N.M., Muhammad Nawawi, K.N. and Ali, R.A.R. (2019) A Randomized Double-Blind Placebo-Controlled Trial of Probiotics in Post-Surgical Colorectal Can-cer. BMC Gastroenterology, 19, Article No. 131.
https://doi.org/10.1186/s12876-019-1047-4
|
[34]
|
Fang, Y., Zhang, C., Shi, H., et al. (2021) Characteristics of the Gut Microbiota and Metabolism in Patients with Latent Autoimmune Diabetes in Adults: A Case-Control Study. Diabe-tes Care, 44, 2738-2746.
https://doi.org/10.2337/dc20-2975
|
[35]
|
Lee, Y.-S., Lee, D., Park, G.-S., et al. (2021) Lactobacillus plantarum HAC01 Ameliorates Type 2 Diabetes in High-Fat Diet and Streptozotocin-Induced Diabetic Mice in Association with Modulating the Gut Microbiota. Food & Function, 12, 6363-6373. https://doi.org/10.1039/D1FO00698C
|
[36]
|
Watanabe, A., Tochio, T., Kadota, Y., et al. (2021) Supplementation of 1-Kestose Modulates the Gut Microbiota Composition to Ameliorate Glucose Metabolism in Obesity-Prone Hosts. Nu-trients, 13, Article No. 2983.
https://doi.org/10.3390/nu13092983
|